Authors: Jordis, U Kesselgruber, M Nerdinger, S

Citation: U. Jordis et al., New C-substituted (1S,4S)-2,5-diazabicyclo[2.2.1]heptane derivatives. Preparation utilizing the directed metalation strategy. Application in enantioselective catalysis, ARKIVOC, 2, 2001, pp. 1149-1161

Authors: Treu, M Jordis, U Mereiter, K

Citation: M. Treu et al., 12H-[2]-benzothiepino[6,5a,5-bc]benzofuran: Synthesis of a sulfur-analog of galanthamine, HETEROCYCLE, 55(9), 2001, pp. 1727

Authors: Krebs, HA Jordis, U

Citation: Ha. Krebs et U. Jordis, How to add Chemical Abstracts Service Registry Numbers and structures to databases via chemical names comparison, J CHEM INF, 40(2), 2000, pp. 293-294

Authors: Rizzi, A Schuh, R Bruckner, A Cvitkovich, B Kremser, L Jordis, U Frohlich, J Kuenburg, B Czollner, L

Citation: A. Rizzi et al., Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors, J CHROMAT B, 730(2), 1999, pp. 167-175

Authors: Kuenburg, B Czollner, L Frohlich, J Jordis, U

Citation: B. Kuenburg et al., Development of a pilot scale process for the anti-Alzheimer drug (-)-galanthamine using large-scale phenolic oxidative coupling and crystallisation-induced chiral conversion, ORG PROC R, 3(6), 1999, pp. 425-431

Authors: Jordis, U Kesselgruber, M Nerdinger, S Mereiter, K

Citation: U. Jordis et al., New 2,5-diazabicyclo[2.2.1]heptanes and their application in the asymmetric addition of diethylzinc to benzaldehyde, MENDELEEV C, (4), 1999, pp. 147-148